Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
48
EWTX Quote, Financials, Valuation and Earnings
Last price:
$30.78
Seasonality move
:
26.98%
Day range:
$30.06 - $32.61
52-week range:
$9.00 - $38.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.95x
Volume:
1.1M
Avg. volume:
811.9K
1-year change:
261.22%
Market cap:
$2.9B
Revenue:
--
EPS (TTM):
-$1.50
Earnings Data
Next earnings date for EWTX
Feb 21
2025
Most recent earnings per share
-$0.36
Beat by $0.01
(Nov 7/2024)
Consensus Estimate
-$0.37
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EWTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/21/2025 | Q4 | -- | -- | -- | -$0.42 | -- |
| 11/07/2024 | Q3 | -- | -- | -$0.36 | -$0.37 | $0.01 |
| 08/08/2024 | Q2 | -- | -- | -$0.34 | -$0.34 | $0.01 |
| 05/10/2024 | Q1 | -- | -- | -$0.33 | -$0.41 | $0.08 |
| 02/22/2024 | Q4 | -- | -- | -$0.47 | -$0.43 | -$0.04 |
| 11/09/2023 | Q3 | -- | -- | -$0.41 | -$0.40 | -$0.01 |
| 08/10/2023 | Q2 | -- | -- | -$0.34 | -$0.40 | $0.06 |
| 05/11/2023 | Q1 | -- | -- | -$0.36 | -$0.35 | -$0.01 |
| 02/23/2023 | Q4 | -- | -- | -$0.30 | -$0.33 | $0.03 |
| 11/03/2022 | Q3 | -- | -- | -$0.34 | -$0.36 | $0.02 |
| 08/04/2022 | Q2 | -- | -- | -$0.32 | -$0.33 | $0.01 |
| 05/11/2022 | Q1 | -- | -- | -$0.30 | -$0.28 | -$0.02 |
| 02/24/2022 | Q4 | -- | -- | -$0.24 | -$0.26 | $0.02 |
| 11/10/2021 | Q3 | -- | -- | -$0.26 | -$0.24 | -$0.02 |
| 08/09/2021 | Q2 | -- | -- | -$0.21 | -$0.17 | -$0.04 |
| 05/13/2021 | Q1 | -- | -- | -$4.37 | -$0.15 | -$4.22 |
| 12/31/2020 | Q4 | -- | -- | -$0.14 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.16 | -- | -- |
Edgewise Therapeutics Earnings Questions
-
How Much did Edgewise Therapeutics Generate in Revenue Last Quarter?
Edgewise Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Edgewise Therapeutics Beat Earnings Last Quarter?
Edgewise Therapeutics announced earnings per share of -$0.36 which represents a beat of analyst forecast a -$0.37 per share.
-
Is Edgewise Therapeutics Profitable?
Edgewise Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Edgewise Therapeutics EPS Next Year?
Edgewise Therapeutics's earnings are forecast to decrease from -$1.57 per share to -$1.54 per share next year representing a decrease of -5.67%.
-
When is Edgewise Therapeutics's Earnings Date?
Edgewise Therapeutics's next earnings date is February 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
